Patients

Teva Canadian MS Community: No Win for the Company

Teva is closing its community forum from its Canadian multiple sclerosis education website because of Canadian healthcare regulations around dissemination of information relating to prescription drugs. You’ll read the explanation if you visit the Teva MS website, but keep reading for the crux of the situation: I have to agree with Teva’s decision because it [...]

Read the full article →

Which Side Are You Really On, Jane Chin?!

I received what is probably the most passionate email from a reader of this blog that I’ve ever gotten since creating NakedMedicine.com in 2006. The email concludes with this: I can’t figure out what your agenda is Ms Chin. Are siding with the poor hard working physicians who are fighting a losing battle with their [...]

Read the full article →

Pharma Offering Lifestyle Drugs – Power will Shift to Patient Customers

You’ve probably seen it coming – smelled hints of it on TV – pharmaceutical companies are getting into what we call “lifestyle drugs”; products that focus on “enhancing” your life rather than “extending” it. Yes, there is a big difference, and you may think that “extending” life pays big, “enhancing” life may pay even BIGGER. [...]

Read the full article →

Pharma Industry’s Job is NOT Disease Prevention. THAT’S YOUR JOB.

I’ve heard the argument, so have you. “Those evil pharma companies aren’t interested in prevention! They want people to get sick and stay sick because that’s how they make their money! On the drugs!” Recently I had railed against the pharma companies that are capitalizing on increasing trends of people using certain prescription drugs as [...]

Read the full article →

The Forgotten Benefits of Aspirin

By Dan Abshear Almost on a daily basis, one may read about a new medication being developed or approved for the benefit of patients. At times, these announcements may praise the innovation and novelty of such drugs that are new and possibly available to all in need of it. But it’s possible the one super [...]

Read the full article →